XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.87

-1.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (9364)	3/24/1999 6:34:00 PM
From: Bluegreen	Read Replies (1) of 17367

I think with the limited amount of facts and data, Bob, Cacaito and SL have done a wonderful job of explaining things. Can you imagine how these individuals would shine if they had all the facts and data? In my opinion I now think that Murphy might be correct in speculating treated group had no deaths because I don't think it would be that hard to improve on Phase II open label results. Think about the physical characteristics of the young person that died in open label Phase II. Was that only a coincidence that the only one who died had those physical characteristics? What would be the chances of getting another like that in treated arm of Phase III? Once again, only my opinions.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next